Avantor, Inc., a global provider of products and services to the life sciences and advanced technologies & applied materials industries, has acquired RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
 
RIM Bio’s Changzhou, China facility is Avantor’s first single-use production plant in the AMEA region, building on the company’s existing single-use manufacturing network in the Americas and Europe and greatly increasing capacity to meet growing global demand in bioprocessing leveraging RIM Bio’s technologies and best-in-class lead times.
 
Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor, said, “Adding RIM Bio enables Avantor to better serve our customers by expanding our single-use manufacturing, distribution, and cleanroom capabilities to the AMEA region. RIM serves as an anchor for us to build our presence in this key region, as we better position Avantor to capture long-term opportunities in the growing, global Bioproduction space.”
 
RIM Bio provides a complete range of single-use 2D bags, 3D bags, tank liners, bag assemblies and multi-bag manifolds used in the manufacturing of biologics including monoclonal antibodies (mAbs), vaccines, cell and gene therapies, and recombinant proteins.
 
In December 2019, Avantor opened its Shanghai Innovation & Customer Support center, a dedicated bioprocessing facility focused on research, application development and process optimization solutions for biopharma companies across AMEA.